{
    "2021-04-06": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Abbott's XIENCEâ„¢ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients",
                "features": {
                    "keywords": [
                        "XIENCE Stent",
                        "European Approval",
                        "One-Month DAPT",
                        "High Bleeding Risk",
                        "Patients"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}